Recently a cheap and decade old chemotherapy drug was found to be effective in prolonging the life of persons on standard hormone therapy and whose prostate cancer has widely metastasized. The men who received docetaxel, sold as Taxotere and in generic form lived a year more than persons who were not administered this drug.

One of the fallouts of having cancer is the economic costs which the disease inflicts on the patient. This has led to doctors revising their past notes with positive results.

 

Dr. Christopher Sweeney of Dana-Farber Cancer Institute in Boston who led the study and shared the results said that it was a big step in prolonging the life of prostate cancer patients. The results were published on Sunday at the American Society of Clinical Oncology’s annual conference in Chicago.

Prostate Cancer is one of the most common forms of cancer and about 240,000 new cases are diagnosed every year in US. Of these about 30,000 patients have cancer which has spread to other regions of the body like bones or other organs.

The study included 790 men who received drugs to block testosterone. The hormone Testosterone helps in the cancer’s growth. Of the 790 men half were administered six infusions of docetaxel, once every three weeks. About 2 1/2 years later, 101 of the men given docetaxel had died versus 136 of the men who did not receive it. Most of the patients were able to tolerate the treatment except 1 patient who died and 6% had fevers from low blood counts.

The study also brought into sharp focus the importance of Federal funding. Dr. Clifford Hudis, who works at Memorial Sloan Kettering Cancer Center in New York and also is the president of the oncology society said, “These are often studies that industry is less interested in funding, such as a new use for an old drug that lost patent protection long ago.”

Generic docetaxel is much cheaper as compared to conventional cancer drugs whose costs can exceed $100,000 for a single course. A course of docetaxel costs about $1,500 or less per infusion.

 

15 Responses

  1. New Approach May Boost Survival From Advanced Prostate Cancer – Philly.com | Jacuzzi Review 2014

    […] prostate cancer, a new study finds. The study was to be presented Sunday in Chicago …New drug helps prostate cancer survival in faster recoveryThe Westside StoryNew technique to help prostate cancer patients fight the diseaseTechsoniaCheap […]

    Reply
  2. Early Chemo May Help Men With Prostate Cancer Live Longer, Study Says – TIME | Fashion Shoes UK

    […] & HealProstate cancer drug delivers benefits before chemotherapyScience CodexPhilly.com -The Westside Story -Techsoniaall 152 news […]

    Reply
  3. Cheap drug boosts prostate cancer survival – WABC-TV | emedicalnews.net

    […] doctors reported Sunday. Men who received docetaxel, sold as Taxotere and in generic …New drug helps prostate cancer survival in faster recoveryThe Westside StoryNew technique to help prostate cancer patients fight the diseaseTechsoniaChemo […]

    Reply
  4. New Approach May Boost Survival From Advanced Prostate Cancer – Philly.com « Left Health Online Medical Store

    […] prostate cancer, a new study finds. The study was to be presented Sunday in Chicago …New drug helps prostate cancer survival in faster recoveryThe Westside StoryNew technique to help prostate cancer patients fight the diseaseTechsoniaCheap […]

    Reply
  5. Study May Alter Approach to Prostate Cancer – New York Times | emedicalnews.net

    […] Metastatic Prostate Cancer PatientsCancer NetworkThe Utah People’s Post -Medscape -The Westside Storyall 81 news […]

    Reply
  6. ASCO: A ‘Home Run’ in Prostate Cancer Tx – MedPage Today | Jacuzzi Review 2014

    […] drug extends lives of men with Prostate Cancer: StudyThe Utah People’s PostMedscape -The Westside Story -The Australianall 75 news […]

    Reply
  7. Study May Alter Approach to Prostate Cancer – New York Times | emedicalnews.net

    […] drug extends lives of men with Prostate Cancer: StudyThe Utah People’s PostMedscape -The Westside Story -Washington Postall 76 news […]

    Reply
  8. Study May Alter Approach to Prostate Cancer – New York Times | HNW

    […] Results for Metastatic Prostate CancerMedscapeThe Utah People’s Post -The Westside Story -Inquirer.netall 74 news […]

    Reply
  9. ASCO: A ‘Home Run’ in Prostate Cancer Tx – MedPage Today | Health News

    […] StudyThe Utah People’s PostPractice-Changing Results for Metastatic Prostate CancerMedscapeThe Westside Story -Washington Postall 71 news […]

    Reply
  10. Study: Cheap chemo drug greatly boosts survival for men with advanced … – CTV News | Health News

    […] drug extends lives of men with Prostate Cancer: StudyThe Utah People’s PostMedscape -The Westside Story -STLtoday.comall 71 news […]

    Reply
  11. ASCO: A 'Home Run' in Prostate Cancer Tx – MedPage Today | HNW

    […] cheap drug extends lives of men with Prostate Cancer: StudyThe Utah People’s PostThe Westside Story -Washington Postall 71 news […]

    Reply
  12. ASCO: A ‘Home Run’ in Prostate Cancer Tx – MedPage Today | emedicalnews.net

    […] StudyThe Utah People’s PostPractice-Changing Results for Metastatic Prostate CancerMedscapeThe Westside Story -Washington Postall 72 news […]

    Reply
  13. ASCO: A 'Home Run' in Prostate Cancer Tx – MedPage Today | HNW

    […] cheap drug extends lives of men with Prostate Cancer: StudyThe Utah People’s PostThe Westside Story -SFGateall 71 news […]

    Reply
  14. ASCO: A 'Home Run' in Prostate Cancer Tx – MedPage Today | HNW

    […] cheap drug extends lives of men with Prostate Cancer: StudyThe Utah People’s PostThe Westside Story -Washington Postall 75 news […]

    Reply
  15. ASCO: A 'Home Run' in Prostate Cancer Tx – MedPage Today | HNW

    […] cheap drug extends lives of men with Prostate Cancer: StudyThe Utah People’s PostThe Westside Story -SFGateall 72 news […]

    Reply

Leave a Reply

Your email address will not be published.